April 24, 2024 11:36 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Renowned dancer and ex-professor at Chennai academy arrested on sexual harassment charges | 'Has anyone robbed your mangalsutra during Congress rule?' Priyanka Gandhi counters PM's charge | 'Can explain manifesto to PM Modi': Mallikarjun Kharge on Muslim League remark | 'They want to break country': PM Modi's jibe over Goa Congress leader's constitution remarks | Under construction Telangana bridge collapses as high wind gushes through the area
Oxford vaccine to be 95 pc effective at par with Moderna and Pfizer, says maker AstraZeneca Coronavirus Vaccine

Oxford vaccine to be 95 pc effective at par with Moderna and Pfizer, says maker AstraZeneca

India Blooms News Service | @indiablooms | 27 Dec 2020, 07:49 pm

New Delhi/IBNS: Oxford coronavirus vaccine manufacturer AstraZeneca has claimed that it will shield 95 per cent of the patients and be as effective as Moderna and Pfizer alternatives though the British-Swedish pharma giant is yet to release the data confirming the claim, said media reports.

Last month, the interim results of the phase III trials data released by the pharma company showed that the vaccine has a 70 per cent rate of effectiveness as an average of two doses. However,  AstraZeneca told British daily the Sunday Times that the scientists have come up with a "winning formula to get efficacy up there with everyone else".

Chief Executive of AstraZeneca Pascal Soriot said the Oxford vaccine will not only have a rate of efficacy of 95 per cent but also should be effective against the newly surfaced aggressive mutant strain which was first detected in the UK in September last.

According to media reports, the Drugs Controller General of India (DCGI) is waiting for the British drug regulator to clear the Oxford vaccine for emergency use authorisation in India.

Apart from the Oxford vaccine, Pfizer and Bharat Biotech are the other two vaccines being considered for emergency use authorisation.

Compared to the vaccine manufactured by Pfizer and Moderna, Oxford vaccine is priced much lower. While Pfizer and Moderna vaccines cost $$20 and $25, respectively, Oxford vaccine costs just $ 2.5.

Meanwhile, Union Health Minister Harsh Vardhan said India would start vaccination in any week of January as the government is preparing to roll out whichever vaccine is cleared first.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.